Caxton Associates (New York)’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,956
Closed -$1.05M 455
2023
Q2
$1.05M Sell
4,956
-2,714
-35% -$575K 0.16% 141
2023
Q1
$1.71M Buy
+7,670
New +$1.74M 0.26% 68
2020
Q4
Sell
-1,859
Closed -$355K 180
2020
Q3
$355K Buy
+1,859
New +$331K 0.04% 168
2018
Q4
Sell
-3,901
Closed -$376K 326
2018
Q3
$376K Sell
3,901
-8,923
-70% -$813K 0.03% 279
2018
Q2
$1.12M Buy
+12,824
New +$1.14M 0.06% 155
2017
Q3
Sell
-8,009
Closed -$599K 515
2017
Q2
$599K Sell
8,009
-225
-3% -$16.8K 0.02% 263
2017
Q1
$624K Buy
+8,234
New +$613K ﹤0.01% 197
2016
Q4
Sell
-135,360
Closed -$9.41M 224
2016
Q3
$9.41M Buy
+135,360
New +$9.59M 0.32% 52
2016
Q2
Sell
-22,317
Closed -$1.42M 183
2016
Q1
$1.42M Buy
+22,317
New +$1.33M 0.1% 95
2014
Q1
Sell
-48,247
Closed -$2.5M 187
2013
Q4
$2.5M Buy
+48,247
New +$2.37M 0.08% 110

Other funds holding DHR

Caxton Associates (New York)'s DHR Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Danaher (DHR) in Q3 2023, closing a stake of 4,956 shares — an estimated $1.05M sold.

Caxton Associates (New York) first reported a position in DHR in Q4 2013 and held it in 10 quarters. The position peaked at $9.41M in Q3 2016. 2,087 funds tracked by Wall St. Rank hold DHR as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Danaher position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,956 Danaher shares in Q3 2023, an estimated $1.05M.
  • Caxton Associates (New York) first reported a position in Danaher in Q4 2013 and held it in 10 quarters.
  • Caxton Associates (New York)'s Danaher position peaked at $9.41M in Q3 2016.
  • 2,087 funds tracked by Wall St. Rank held Danaher as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.